🔵 ECOPATAGONIA SUMMIT 2026
💡Actualizate en Imágenes Cardiovasculares, Medicina Vascular y Salud Digital en el corazón de la Patagonia. ❄️
📍 El Calafate, Santa Cruz
📅 19 al 22 de marzo de 2026
⏰ Reservá antes del 31 de enero
📌Más información 👉🔗 https://t.co/8nhVKotnON
@NMerke N1 is correct, it is important to see "spectral window" (Ventana espectral in spanish), besides all the other characteristics mentioned before. Great thread.
The beta-blocker fallacy in HCM/HFpEF/Amyloidosis
- blunted heart rate response during exercise
- prolonge diastole -> increase filling pressures
- no evidence for better CFR in non obstr. HCM
- no evidence for antiarrhythmic effects in HCM
- increased mortality in subgroups of HFpEF with supranormal EF
Some patient phenotypes will still experience benefits, but one-size does not fit all in HFpEF and CMPs
Beta-blockers in non-obstructive hypertrophic cardiomyopathy: time to ease the heart rate restriction? https://t.co/Ki8EoT09Mb
IMÁGENES SAC23.
Hoy 8,30 hs en el HotelNH City estaré presidiendo, junto al Dr Rodrigo Cano una muy interesante mesa de Imágenes Cardiacas Avanzadas: Como evaluar masas Cardiacas?
Imperdible para todo el que haga Imágenes Cardiacas y Cardiologo Clinico. Los esperamos !
“Pure” severe AS without concomitant valvular heart diseases #VHD: echocardiographic #echofirst and pathophysiological features
J. Kandels et al. @StephanStobe@AHagendorff
✅ https://t.co/TqYsPQR9gL